Micafungin Olikla

Micafungin, the active ingredient in Micafungin Olikla, is an echinocandin antifungal presented as an intravenous formulation for intravenous use. It treats invasive candidiasis, esophageal candidiasis, intra‑abdominal Candida infections and is used for prophylaxis in hematopoietic stem‑cell transplant patients.

GNH USA supplies Micafungin Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Micafungin is an echinocandin antifungal that targets Candida species in serious systemic infections. - Invasive candidiasis: eliminates bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: resolves fungal infection of the esophagus. - Candida peritonitis and intra‑abdominal infections: treats Candida‑related abdominal sepsis. - Prophylaxis of Candida infections in hematopoietic stem cell transplantation: prevents invasive fungal disease in transplant recipients.

Micafungin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Fever: transient temperature rise after infusion. - Nausea: mild gastrointestinal upset. - Headache: occasional mild to moderate headache. - Elevated liver enzymes: transient increase in ALT/AST. - Rash: mild skin erythema or pruritus. - Infusion‑related reactions: flushing or mild hypotension.

Serious or Rare Side Effects: - Hepatic failure: rare but severe liver injury. - Anaphylaxis: immediate hypersensitivity reaction. - Severe hypersensitivity: including Stevens‑Johnson syndrome. - Acute renal failure: uncommon renal impairment. - Severe neutropenia: rare drop in white blood cells.

When using Micafungin, clinicians should consider several safety measures. - Liver function monitoring: check ALT/AST before and during therapy. - Renal function assessment: evaluate creatinine clearance in patients with kidney disease. - Hepatic impairment dosing: adjust or avoid in severe liver dysfunction. - Hypersensitivity caution: discontinue if signs of allergic reaction appear. - Cardiac monitoring: observe for hypotension during infusion. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin may interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Cyclosporine: increased exposure leading to nephrotoxicity. - Tacrolimus: elevated blood levels and risk of toxicity. - Sirolimus: heightened immunosuppressive effect. - Rifampin: strong enzyme induction reduces Micafungin efficacy. - Carbamazepine: induces metabolism, lowering drug concentrations.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole): may increase Micafungin levels. - Warfarin: potential alteration of anticoagulant effect. - Statins: monitor for increased risk of myopathy. - Oral contraceptives: possible reduction in hormonal efficacy. - Phenytoin: may modestly decrease Micafungin exposure.